J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):235-243. doi: 10.1016/j.japh.2019.11.005. Epub 2019 Dec 9.
This study explored the attitudes of the Arkansas community toward medical cannabis (MC) regulation and the role of pharmacists in dispensing MC before the product became available and examined whether participants' demographics (e.g., age, gender) and characteristics (e.g., history of cannabis use) were associated with these attitudes.
Cross-sectional survey.
Using social media, a university research registry, and posted flyers, we invited residents of Arkansas to participate in the self-administered online survey study during a 3-month period, February to April, in 2018.
Five questions that inquired about participants' attitudes toward MC regulation and pharmacists' roles regarding MC use.
Participants (n = 1343) who completed at least 1 of the 5 questions were included. The majority were aged 40-64 years (52.2%), female (69.1%), and white (88.7%). Most participants reported a history of cannabis use (81.8%) and possession or intention to apply for an MC card (52.9%). Among the conditions approved for MC use, pain (20.3%), arthritis (15.4%), and posttraumatic stress disorder (14.5%) were reported frequently. Likewise, prescription use for mood disorders (46.1%) and pain (37.4%) were also reported. In multivariable regression analyses, participants' history of cannabis use was associated with a preference for lesser oversight of MC, disagreement with MC being available through a pharmacy only, and disagreement on whether MC should be regulated before it is legalized for recreational use (all P < 0.001). It was also associated with a decrease in agreement that pharmacists are well-trained to improve patient safety (P < 0.001) and counsel patients regarding appropriate MC use (P = 0.032).
Participants who had previously used cannabis were in favor of fewer restrictions and negatively perceived pharmacists' involvement in ensuring appropriate dispensing and MC use. The findings may highlight the need for Arkansas pharmacists to explore alternative ways to promote the safe and proper MC use.
本研究旨在探讨阿肯色州社区对医用大麻(MC)监管的态度,以及在该产品上市前药剂师在分发 MC 方面的作用,并调查参与者的人口统计学特征(如年龄、性别)和特征(如大麻使用史)是否与这些态度有关。
横断面调查。
在 2018 年 2 月至 4 月的三个月期间,我们通过社交媒体、大学研究登记处和张贴传单,邀请阿肯色州的居民参与这项自我管理的在线调查研究。
询问参与者对 MC 监管的态度和药剂师在 MC 使用方面的作用的 5 个问题。
完成至少 1 个 5 个问题的参与者(n=1343)被纳入分析。大多数参与者年龄在 40-64 岁之间(52.2%),女性(69.1%),白人(88.7%)。大多数参与者报告有大麻使用史(81.8%)和拥有或打算申请 MC 卡(52.9%)。在批准用于 MC 的疾病中,疼痛(20.3%)、关节炎(15.4%)和创伤后应激障碍(14.5%)报告频率较高。同样,也报告了用于治疗情绪障碍(46.1%)和疼痛(37.4%)的处方用途。在多变量回归分析中,参与者的大麻使用史与对 MC 监管较少、反对仅通过药店提供 MC 以及反对在娱乐用途合法化之前对 MC 进行监管的偏好有关(均 P<0.001)。它还与降低对药剂师在提高患者安全性方面训练有素的认同(P<0.001)和在适当使用 MC 方面对患者进行咨询的能力(P=0.032)有关。
有过大麻使用史的参与者赞成减少限制,并对药剂师参与确保 MC 正确分发和使用持负面看法。研究结果可能突出表明,阿肯色州的药剂师需要探索促进 MC 安全和正确使用的替代方法。